Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Hackshaw

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
BMJ (Clinical Research Ed.)|January 10, 2012
Benefits and harms of mammography screeningAllan Hackshaw
BMJ Oncology|January 31, 2025
Modern cancer trials still lack information about QoL impacts on patientsAllan Hackshaw
Journal of Medical Screening|September 14, 2012
The benefits and harms of mammographic screening for breast cancer: building the evidence base using service screening programmesAllan Hackshaw
BMJ (Clinical Research Ed.)|August 30, 2003
Passive smoking: paper does not diminish conclusion of previous reportsAllan Hackshaw,
Expert Opinion on Pharmacotherapy|October 31, 2009
Luteinizing hormone-releasing hormone (LHRH) agonists in the treatment of breast cancerAllan Hackshaw
BMJ (Clinical Research Ed.)|July 6, 2011
Interpreting and reporting clinical trials with results of borderline significanceAllan Hackshaw, Amy Kirkwood
Prenatal Diagnosis|November 9, 2002
Estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screeningAllan Hackshaw, Nicholas Wald
Clinical Medicine & Research|July 4, 2009
Low versus high I-131 dose for remnant ablation in differentiated thyroid cancerAllan Hackshaw, Ujjal Mallick
British Journal of Cancer|July 17, 2020
Reply to Comment(s) on "Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort"Iain Hutchison, Allan Hackshaw
The Lancet. Oncology|September 30, 2021
An efficient randomised trial design for multi-cancer screening blood tests: nested enhanced mortality outcomes of screening trialAllan Hackshaw, Christine D Berg
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
BMJ (Clinical Research Ed.)|January 10, 2012
Benefits and harms of mammography screeningAllan Hackshaw
BMJ Oncology|January 31, 2025
Modern cancer trials still lack information about QoL impacts on patientsAllan Hackshaw
Journal of Medical Screening|September 14, 2012
The benefits and harms of mammographic screening for breast cancer: building the evidence base using service screening programmesAllan Hackshaw
BMJ (Clinical Research Ed.)|August 30, 2003
Passive smoking: paper does not diminish conclusion of previous reportsAllan Hackshaw,
Expert Opinion on Pharmacotherapy|October 31, 2009
Luteinizing hormone-releasing hormone (LHRH) agonists in the treatment of breast cancerAllan Hackshaw
BMJ (Clinical Research Ed.)|July 6, 2011
Interpreting and reporting clinical trials with results of borderline significanceAllan Hackshaw, Amy Kirkwood
Prenatal Diagnosis|November 9, 2002
Estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screeningAllan Hackshaw, Nicholas Wald
Clinical Medicine & Research|July 4, 2009
Low versus high I-131 dose for remnant ablation in differentiated thyroid cancerAllan Hackshaw, Ujjal Mallick
British Journal of Cancer|July 17, 2020
Reply to Comment(s) on "Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort"Iain Hutchison, Allan Hackshaw
The Lancet. Oncology|September 30, 2021
An efficient randomised trial design for multi-cancer screening blood tests: nested enhanced mortality outcomes of screening trialAllan Hackshaw, Christine D Berg
Pageof 17